Рефрактерная форма гастроэзофагеальной рефлюксной болезни. Актуальные и нерешенные вопросы консервативной терапии

Осадчук Алексей Михайлович, Давыдкин Игорь Леонидович, Палушкина Мария Григорьевна · Medical Almanac · 2012

The prevalence of heartburn, the main symptom of gastroesophageal reflux disease (GERD) is about 30-40% in the population. While about half of patients with GERD suffer heartburn. Proton pump inhibitors (RTIs) are the primary medications in the treatment of GERD. In recent years there had been increasing the frequency of refractory to treatment with Proton pump inhibitors (RTIs) GERD. Refractory forms of GERD (RFGERD) are a significant reduction in the quality of life of the patient, high frequency of Barrett's esophagus, which is the background for the formation of esophageal cancer. It is proved that in maintaining refractory GERD importance belongs to the restructuring of uterine diffuse endocrine system (DES), inducing violation processes of cellular homeostasis and thus increase the risk of Barrett's esophagus and esophageal cancer. It is now proposed to a large number of conservative treatment capable of resisting development RFGERD. In addition to the traditional means used in the treatment of RFGERD (prokinetic, choleretic, antacid drugs) as a complementary therapy, proposes alternative methods of such patients. Among the promising treatments RFGERD are medicines that can affect the DES (melaksen, oktreodit) and the processes of cell homeostasis with citoprotektive effect (methionine, dibikor).

Cited by 0 works.

Authors